Kazuaki Shimamoto

Overview

Best Publications

• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

  Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  1378
  Citations

• The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014)

  Kazuaki Shimamoto;Katsuyuki Ando;Toshiro Fujita;Naoyuki Hasebe

  1126
  Citations

• Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1

  Masaya Tanno;Jun Sakamoto;Tetsuji Miura;Kazuaki Shimamoto

  1005
  Citations

• Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension

  Masato Furuhashi;Nobuyuki Ura;Katsuhiro Higashiura;Hideyuki Murakami

  656
  Citations

• Erratum: The Japanese Society of hypertension guidelines for the management of hypertension (Hypertension Research (2009) 32 (11-23) DOI: 10.1038/hr.2008.2)

  Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  608
  Citations

• Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.

  Masato Furuhashi;Shigeyuki Saitoh;Kazuaki Shimamoto;Tetsuji Miura

  504
  Citations

• Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study

  Toshio Ogihara;Takao Saruta;Hiromi Rakugi;Hiroaki Matsuoka

  469
  Citations

• Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure.

  Masaya Tanno;Atsushi Kuno;Toshiyuki Yano;Tetsuji Miura

  456
  Citations

• Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance

  Ryuzo Kawamori;Naoko Tajima;Yasuhiko Iwamoto;Atsunori Kashiwagi

  385
  Citations

• Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese

  Tamio Teramoto;Jun Sasaki;Hirotsugu Ueshima;Genshi Egusa

  379
  Citations

• Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

  Masunori Matsuzaki;Toru Kita;Hiroshi Mabuchi;Yuji Matsuzawa

  347
  Citations

• Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study

  Kazuaki Shimamoto;Naoyuki Hasebe;Sadayoshi Ito;Kazuomi Kario

  338
  Citations

• High plasma immunoreactive leptin level in essential hypertension.

  Jun Agata;Atsushi Masuda;Mikio Takada;Katsuhiro Higashiura

  332
  Citations

• The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

  Toshio Ogihara;Kenjiro Kikuchi;Toshiro Fujita;Jitsuo Higaki

  326
  Citations

• Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection

  Masahiro Nishihara;Tetsuji Miura;Takayuki Miki;Masaya Tanno

  316
  Citations

• Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

  Masato Furuhashi;Norihito Moniwa;Tomohiro Mita;Takahiro Fuseya

  306
  Citations

• Diagnostic Criteria for Dyslipidemia — Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese

  Tamio Teramoto;Jun Sasaki;Hirotsugu Ueshima;Genshi Egusa

  292
  Citations

• Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study

  Takeshi Isobe;Shigeyuki Saitoh;Satoru Takagi;Hiroshi Takeuchi

  263
  Citations

• Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts

  Tomoaki Nakata;Kenjiroh Miyamoto;Atsushi Doi;Hisataka Sasao

  252
  Citations

• Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

  Toshio Ogihara;Takao Saruta;Hiromi Rakugi;Kazuaki Shimamoto

  250
  Citations